By understanding why certain nerve cells and the muscles they control are resistant to fading in the deadly disease ALS, it is possible to create new possibilities for treatments.
A most dangerous poison can be of great benefit as a drug
Through molecular genealogy, Pål Stenmark (professor of biochemistry) has found a new family of botulinum toxins, where a variant can fight malaria mosquitoes.
A salt transporter linked to hypertension and diabetes
Researchers at Stockholm University shed new light on how transporter-protein exchangers the movement of sodium ions across cell membranes with the movement of protons.
We offer a broad selection of specialized courses held in English that can be taken both as freestanding courses or as part of one of our Master's programmes.
In a new study published in Nature Communications, researchers from Stockholm University show for the first time how NrdR binds to DNA to inhibit RNR. The novel mechanism could help scientists design better antibiotics by targeting a pathogen’s ability to reproduce.
Researchers have mapped the physicochemical properties of proteins in 20,000 organisms. The results, published in The Proceedings of the National Academy of Sciences (PNAS), show that the properties not only provide clues to understanding evolution and adaptation, but also add new dimensions to the established taxonomical classification system.
Ribonucleotide reductase (RNR) is an essential enzyme that catalyzes the synthesis of DNA building blocks. In a new study from Britt-Marie Sjöberg’s and Pål Stenmark’s groups at DBB, they present several cryo-EM structures and the mechanism of action of NrdR. NrdR is the RNR-specific repressor, that controls transcription of RNR genes in bacteria. The repressor uses an unprecedented nucleotide-sensing oligomerization mechanism to control NrdR-dependent transcription of ribonucleotide reductases.